Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CV Sciences Inc CVSI

Consumer Defensive Household & Personal Products
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). It also operates a drug development program focused on developing and commercializing cannabidiol... see more

OTCQB:CVSI - Post Discussion

CV Sciences Inc > DionyMed Brands Inc. Announces First Quarter 2019 n kills it
View:
Post by Bigchungus on Jun 10, 2019 10:59pm

DionyMed Brands Inc. Announces First Quarter 2019 n kills it

14.2mm USD or 19mm CAD Q1 revenue. Approaching an annual run rate of 80mm CAD and a mere 100mm cap. This e-commerce platform distributes to over 900 retailers and makes thousands of direct to consumer deliveries daily and is expanding rapidly. This puts DYME in approx 13th on the U.S. overall cannabis revenue generator and exceeds many established Canadian producers sales, including Aphria and other noteworthy LPs. Who wouldn’t want cannabis delivered straight to your door? This company is largely under the radar and worth noting, a near 52w low. Super low float, so this could easily hit the analysts target of $6.00 from its current $2.08 in short order. Anticipated 2019 revenue of 162 million CAD

Order here:  https://www.orderchill.com/

https://www.newcannabisventures.com/cannabis-company-revenue-ranking/
Comment by charliedtrader on Jul 10, 2019 11:34am
This post has been removed in accordance with Community Policy
CV Sciences Inc